Respirich F – montelukast 10 mg + fexofenadine HCL 120 mg tablets

Buy Respirich F – montelukast 10 mg + fexofenadine HCL 120 mg tablets for Bulk Order

What is Respirich F – montelukast 10 mg + fexofenadine HCL 120 mg tablets?

Respirich F is a pharmaceutical formulation combining montelukast (10 mg) and fexofenadine HCL (120 mg). Montelukast is a leukotriene receptor antagonist, while fexofenadine is a selective H1-antihistamine. This combination is primarily used for allergic rhinitis and asthma management, providing dual-action relief.

This product is relevant in both pharmaceutical and industrial contexts, often synthesized in controlled environments to ensure purity and efficacy. Its regulatory classification requires adherence to local and international pharmaceutical standards, making it suitable for clinical applications.

What Are the Applications of Respirich F – montelukast 10 mg + fexofenadine HCL 120 mg tablets?

• Used in the treatment of allergic rhinitis and asthma.
• Formulation of combined therapies for respiratory conditions.
• Research applications in pharmacological studies.
• Contributes to the development of advanced therapeutic regimes.

Why Choose Pharmint as Your Respirich F – montelukast 10 mg + fexofenadine HCL 120 mg tablets Supplier?

Pharmint offers global sourcing capabilities, ensuring access to high-quality pharmaceutical ingredients. Our commitment to regulatory compliance is demonstrated through the provision of Certificates of Analysis (COA) and Material Safety Data Sheets (MSDS). We provide bulk availability with efficient lead times and extensive export support, setting us apart from typical vendors.

Storage & Handling Guidelines for Respirich F – montelukast 10 mg + fexofenadine HCL 120 mg tablets

Store at a controlled room temperature (15°C to 25°C). Protect from light exposure and moisture. Seal the product in its original packaging to prevent contamination and degradation. Bulk or research-grade material packaging is available to suit various procurement needs.

Regulatory, Documentation & Export Information

This formulation is not classified as a controlled precursor and does not require an end-use declaration. Available documentation includes Certificates of Analysis (COA) and Material Safety Data Sheets (MSDS), ensuring compliance with regulatory standards.

Respirich F – montelukast 10 mg + fexofenadine HCL 120 mg tablets FAQs

What is the shelf life of Respirich F?

The shelf life of Respirich F is typically 24 months when stored under recommended conditions. Always refer to the COA for specific details.

How should Respirich F be stored?

Store Respirich F at room temperature away from light and moisture. Ensure the packaging remains sealed until use to maintain integrity.

Is Respirich F suitable for bulk orders?

Yes, Respirich F is available for bulk orders, making it ideal for procurement teams and research facilities needing large quantities.

What documentation is available with Respirich F?

Available documentation includes the Certificate of Analysis (COA) and Material Safety Data Sheet (MSDS) to ensure compliance and safety for users.

Can Respirich F be used in research applications?

Yes, Respirich F is suitable for various research applications, particularly in pharmacological studies exploring respiratory therapies.